A cfDNA-based DNA methylation classifier for distinguishing prostate…
A blood test measuring methylation patterns may help doctors distinguish prostate cancer from benign enlargement more reliably than current PSA testing alone.
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
Diagnostic utility of HPV-16/18 E6 mRNA fold change measured by…
A rapid HPV test measuring E6 mRNA could help identify cervical precancers in resource-limited settings with high sensitivity and specificity.
Early cancer detection or preventionDigital PCR for Detecting Loss of BAP1 and MTAP in Pleural Fluids of…
Digital PCR detecting lost genes in fluid samples shows promise for confirming mesothelioma diagnoses in patients with unclear presentations.
Novel or significantly improved treatmentPerioperative Durvalumab for Resectable NSCLC
Japanese patients with early-stage lung cancer receiving durvalumab after surgery showed encouraging survival benefits in this exploratory subgroup analysis.
Standard additionReal-world outcomes of nivolumab-AVD and brentuximab vedotin-AVD in…
Real-world data suggest nivolumab-based treatment and standard chemotherapy work comparably well for advanced Hodgkin lymphoma, with trade-offs worth monitoring.